search
Back to results

Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia

Primary Purpose

Fibromyalgia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CES device
sham device
Sponsored by
University of Virginia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Fibromyalgia focused on measuring fibromyalgia, pain, sleep disturbance, fatigue, depression, functional magnetic resonance imaging

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • meet the diagnostic criteria for FM established by the American College of Rheumatology
  • have initial pain level equal to or greater than 3 on a NRS 0-10
  • have stable medication use related to FM for at least 4 weeks
  • be able to read, write, and understand the English language

Exclusion Criteria (all participants):

  • pregnant or breastfeeding
  • epilepsy or history of seizures
  • presence of pacemakers and/or other implanted devices

Exclusion Criteria (subset of 12 participants who wil have fMRIs):

  • conditions that would not permit an fMRI (e.g., certain types of metal or metallic objects in body, diaphragm or intrauterine device, dermal patches, ear or eye implants, implanted electrical stimulators, artificial heart valve, implanted catheter or tube, tattoos, claustrophobia; or weight more than 275 lbs)

Sites / Locations

  • University of Virginia Center for the Study of Complementary and Alternative Therapies

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Sham Comparator

No Intervention

Arm Label

CES device

Sham device

Usual care alone

Arm Description

Participants will use the device for 60 minutes each day for 8 weeks.

Participants will use the device for 60 continuous minutes each day for 8 weeks. The sham device will look the same as the active CES device; however, no electrical stimulation will be present in the sham device.

No intervention; participants will receive usual medical care

Outcomes

Primary Outcome Measures

Pain Intensity Using Numeric Rating Scale
A Numeric Rating Scale ranging from 0 (no pain) to 10 (worst pain imaginable) to capture present pain intensity

Secondary Outcome Measures

Fatigue Using Lee's Fatigue Scale
A Numeric Rating Scale ranging from 0-10 to capture present levels of fatigue using the fatigue subscale of Lee's Fatigue Scale
General Sleep Disturbance Scale
Depression Using the CES-D
Perceived Stress Using Numeric Rating Scale
Functional Status Using the Fibromyalgia Index Questionnaire

Full Information

First Posted
June 24, 2009
Last Updated
June 5, 2018
Sponsor
University of Virginia
search

1. Study Identification

Unique Protocol Identification Number
NCT00928720
Brief Title
Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia
Official Title
Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
October 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Virginia

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the effects of mild cranial electrical stimulation on pain, fatigue, sleep disturbances, perceived stress, blood pressure, and functional status in persons with fibromyalgia.
Detailed Description
Central pain networks in the brain are dysregulated in persons with fibromyalgia (FM). Thus, the investigators propose that cranial electrical stimulation (CES) that works on the brain may ameliorate symptoms of FM by interacting with the central pain networks. The specific aims of this randomized, controlled, three-group pilot study design are to: (1) determine differences in pain over time between the active CES, sham device, and usual care (UC) groups; (2) explore differences in brain activity in pain processing regions (i.e., cingulate, insula, prefrontal and somatosensory cortices, amygdala, and thalamus) between the active CES, sham device, and UC groups in a subset of 12 participants (6 in each device group); (3) determine the effects of CES on other symptoms (fatigue, sleep disturbances, depression, perceived stress) and functional status, and blood pressure over time between the active CES, sham device, and UC groups; and (4) determine the amount of influence that selected psychological factors (negative affect, catastrophizing, and other personality characteristics) have on group differences in pain, other symptoms, functional status, and brain activity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
Keywords
fibromyalgia, pain, sleep disturbance, fatigue, depression, functional magnetic resonance imaging

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
57 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CES device
Arm Type
Active Comparator
Arm Description
Participants will use the device for 60 minutes each day for 8 weeks.
Arm Title
Sham device
Arm Type
Sham Comparator
Arm Description
Participants will use the device for 60 continuous minutes each day for 8 weeks. The sham device will look the same as the active CES device; however, no electrical stimulation will be present in the sham device.
Arm Title
Usual care alone
Arm Type
No Intervention
Arm Description
No intervention; participants will receive usual medical care
Intervention Type
Device
Intervention Name(s)
CES device
Other Intervention Name(s)
Alpha-Stim
Intervention Description
Participants will use the device for 60 continuous minutes each day for 8 weeks. The CES device will be preset at the factory to provide a maximum of 60 minutes of modified square-wave biphasic stimulation at 0.5 Hz and 100µA, the lowest setting that has been used in previous studies with patients with FM.
Intervention Type
Device
Intervention Name(s)
sham device
Intervention Description
The sham device will look the same as the active CES (Alpha-Stim); however, no electrical stimulation will be present in the sham device.
Primary Outcome Measure Information:
Title
Pain Intensity Using Numeric Rating Scale
Description
A Numeric Rating Scale ranging from 0 (no pain) to 10 (worst pain imaginable) to capture present pain intensity
Time Frame
week 8
Secondary Outcome Measure Information:
Title
Fatigue Using Lee's Fatigue Scale
Description
A Numeric Rating Scale ranging from 0-10 to capture present levels of fatigue using the fatigue subscale of Lee's Fatigue Scale
Time Frame
Week 8
Title
General Sleep Disturbance Scale
Time Frame
Week 8
Title
Depression Using the CES-D
Time Frame
Week 8
Title
Perceived Stress Using Numeric Rating Scale
Time Frame
Week 8
Title
Functional Status Using the Fibromyalgia Index Questionnaire
Time Frame
Week 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: meet the diagnostic criteria for FM established by the American College of Rheumatology have initial pain level equal to or greater than 3 on a NRS 0-10 have stable medication use related to FM for at least 4 weeks be able to read, write, and understand the English language Exclusion Criteria (all participants): pregnant or breastfeeding epilepsy or history of seizures presence of pacemakers and/or other implanted devices Exclusion Criteria (subset of 12 participants who wil have fMRIs): conditions that would not permit an fMRI (e.g., certain types of metal or metallic objects in body, diaphragm or intrauterine device, dermal patches, ear or eye implants, implanted electrical stimulators, artificial heart valve, implanted catheter or tube, tattoos, claustrophobia; or weight more than 275 lbs)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ann G Taylor, EdD, RN
Organizational Affiliation
University of Virginia
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Virginia Center for the Study of Complementary and Alternative Therapies
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22908
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia

We'll reach out to this number within 24 hrs